Search clinical trials for: clopidogrel and placebo

Total 282909 results

Sir Run Run Shaw Hospital

Unknown

Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation (EASTS)

Coronary Artery Disease
University Hospital, Toulouse

Completed

TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement (TIRATROP)

Atherosclerosis

France
University of Pecs

Terminated

Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity (DOSER)

Stable Angina Pectoris | Ad Hoc Percutaneous Coronary Intervention

Hungary
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event (SWAP)

Acute Coronary Syndrome | Coronary Arteriosclerosis

United States
Karolinska Institutet

Unknown

Bisphosphonates for the Treatment of Seropositive Musculoskeletal Complaints (PREVENT RA)

Seropositive Muskuloskeletal Complaints
The Medicines Company

Terminated

Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. (Platform)

Atherosclerosis | Acute Coronary Syndrome (ACS)

United States
Novo Nordisk A/S

Completed

A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers

Healthy | Haemostasis

United States
Yonsei University

Unknown

Effect of Zoledronic Acid on Prevention of Bone Loss in Acute Phase First-ever Stroke Patients

Stroke

Korea, Republic of
Korea University Anam Hospital

Completed

Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients (MECCA)

Angina, Stable
University Hospital, Bordeaux
Ministry for Health and Solidarity, France

Recruiting

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk (PSSIT)

Systemic Sclerosis | Scleroderma

France
University Hospital, Angers

Unknown

Platelets Induced Vasodilation, in Vitro and in Vivo Study

Peripheral Arterial Disease

France
Chinese University of Hong Kong

Completed

Uninterrupted Clopidogrel Therapy Before Elective Colonoscopy Will Increase the Risk of Post-polypectomy Bleeding

Gastrointestinal Bleeding

China
Sanofi
Bristol-Myers Squibb

Completed

Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy Subjects

Healthy

United States, France
Sanofi
Bristol-Myers Squibb

Completed

Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects

Healthy

Germany
Accumetrics, Inc.

Completed

GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety (GRAVITAS)

Acute Coronary Syndrome | Coronary Arteriosclerosis

United States, Canada
Chinese PLA General Hospital

Unknown

Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS (GI-CT)

CLOPIDOGREL, POOR METABOLISM of (Disorder)

China
Sheba Medical Center

Unknown

Chewing Clopidogrel in Addition to Regular Oral Clopidogrel Treatment to Improve Platelets Aggregation in Patient With NON ST ELEVATION MI

Platlet Aggregation | Major Bleeding Outcomes

Israel
Ospedale San Donato

Completed

Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial Infarction (Load & Go)

Acute Myocardial Infarction

Italy
Austin Health

Completed

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Prostate Cancer

Australia
Sanofi
Bristol-Myers Squibb

Completed

Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation (CLARINET)

Heart Defects, Congenital

France, Canada, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Sweden, India, Malaysia, Singapore, Taiwan, Belgium, Mexico, Argentina, Denmark, Egypt, Finland, Hungary, Israel, Norway, Korea, Republic of, Hong Kong and more
Takeda

Completed

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Healthy

United States
Oslo University Hospital
Sykehuset Ostfold; Betanien Hospital

Terminated

Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter Trial

Stress Fracture Foot | Stress Fracture Ankle

Norway
The Medicines Company

Terminated

A Clinical Trial to Demonstrate the Efficacy of Cangrelor (PCI)

Myocardial Infarction (MI) | Acute Coronary Syndromes (ACS)

United States
Hospital Central San Luis Potosi, Mexico

Unknown

Patent Versus Generic Clopidogrel in Acute Coronary Syndrome

Acute Coronary Syndrome
Lady Reading Hospital, Pakistan
Pakistan Chest Society, Pakistan

Recruiting

Clopidogrel for the Prevention of Exacerbations in Severe COPD (CLOPEX)

COPD | COPD Exacerbation Acute

Pakistan
Deutsches Herzzentrum Muenchen

Terminated

Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation (ISAR-CAUTION)

Coronary Artery Disease

Germany
University of North Carolina, Chapel Hill

Completed

Clopidogrel Pharmacogenomics Project

Disease Susceptibility

United States
Shenyang Northern Hospital
Changhai Hospital; ANKON medical technologies (Shanghai)Co.,LTD

Completed

Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation (OPT-PEACE)

Ischemic Heart Disease | Gastrointestinal Injury

China
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

Coronary Artery Disease

Korea, Republic of
University of Pecs
Hungarian Academy of Sciences; KRKA

Completed

Comparison of Generic and Original Formulation of Clopidogrel (DOSER-GENERIC)

Coronary Heart Disease | Percutaneous Coronary Intervention
Ajou University School of Medicine
Dong-A Pharmaceutical

Completed

Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)

Acute Coronary Syndrome

Korea, Republic of
Novo Nordisk A/S

Terminated

Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding

Healthy | Haemostasis

United States
The Third Xiangya Hospital of Central South University

Completed

Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

Coronary Heart Disease

China
Centre Hospitalier Universitaire de Saint Etienne

Completed

Investigation of Drug-drug Interaction Between Clopidogrel and Fluoxetine (PLATINE)

Healthy

France
University of Pecs

Completed

Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity (TREAT-HPR)

Acute Coronary Syndrome

Hungary
Ain Shams Maternity Hospital

Unknown

Comparison Between Effect of Enoxaparin and Clopidogrel on Improving Pregnancy Rate in ICSI

Female , Infertility

Egypt
Taipei City Hospital

Completed

Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)

Stable Angina

Taiwan
Sanofi
Bristol-Myers Squibb

Completed

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction (CLARITY-TIMI28)

Acute Coronary Syndromes

Russian Federation, Belgium, Brazil, France, Germany, Hungary, Italy, Mexico, Netherlands, South Africa, Spain, Sweden, United States, Argentina, Australia, Ireland, Israel, Turkey, Austria, Poland, Canada, Portugal, Puerto Rico, United...
Seoul National University Hospital
CKD Pharmaceutical Limited

Completed

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

Coronary Heart Disease
Eli Lilly and Company
Daiichi Sankyo, Inc.; The TIMI Study Group

Completed

Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting (PRINCIPLE)

Coronary Artery Disease

France, United States, Israel, Germany
Creighton University

Completed

The Impact of Grapefruit Juice on the Response to Clopidogrel

Healthy

United States
St. Antonius Hospital

Completed

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation (POPular-TAVI)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Disease

Netherlands, Belgium, Czechia, Luxembourg
Khon Kaen University

Completed

Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products

Pharmacodynamics

Thailand
Ruhr University of Bochum

Completed

Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan) (BOCLAplan)

Coronary Artery Disease

Germany
Sanofi
Bristol-Myers Squibb

Completed

Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects

Healthy

United States
Sanofi
Bristol-Myers Squibb

Completed

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

Atrial Fibrillation | Vascular Risk

United States, France, Canada, Brazil, Poland, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Argentina, Denmark, Finland, Hungary, Norway, United... and more
Korea University Anam Hospital

Completed

Genotyping Influences Outcome of Coronary Artery Stenting (GENIUS)

Myocardial Ischemia | CLOPIDOGREL, POOR METABOLISM of (Disorder)
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study

Ischemic Attack, Transient | Stroke, Acute
VA Office of Research and Development

Completed

Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA)

Saphenous Vein Graft Atherosclerosis

United States
Sanofi
Bristol-Myers Squibb

Completed

Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects

Healthy

United States

Search clinical trials for: clopidogrel and placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations